Brain Tunnelgenix Technologies Corporation

Brain Tunnelgenix Technologies Corporation (BTT™ Corp.) is a MedTech innovator specializing in non-invasive, continuous brain temperature monitoring through proprietary brain thermal tunnel technology. Founded on discoveries by Dr. Marc Abreu (Harvard Medical School, Yale School of Medicine), BTT develops FDA-cleared devices and wearable systems that capture real-time brain thermodynamic signatures using advanced microsensors and artificial intelligence. The BTT™ Abreu 700 system represents the first clinically accurate measurement of human brain temperature without corrective factors. The company's integrated platform combines brain thermodynamics, IoT connectivity, and predictive AI models to support diagnosis, monitoring, and therapeutic applications across infectious diseases, neurodegenerative conditions (Alzheimer's, Parkinson's, Multiple Sclerosis), cancer, stroke risk, surgical outcomes, sleep optimization, and performance enhancement. Applications span clinical settings, hospital environments, home monitoring, and occupational wellness programs.